On Oct. 17, smoking cannabis will become legal in Canada. As for cannabis edibles, they will take a bit longer:
Continue reading »
A bad mood may help your brain with everyday tasks
New research found that being in a bad mood can help some people’s executive functioning, such as their ability to
Continue reading »Majority of older adults with probable dementia are likely unaware they have it, study suggests
A Johns Hopkins Medicine analysis of information gathered for an ongoing and federally sponsored study of aging and disability adds
Continue reading »Killer immunotherapy—fighting cancer with genetic engineering
Finding a cure for cancer is no easy feat, but Dr. Misty Jenkins has built her career in immunotherapy to
Continue reading »More youth classified with HTN using new 2017 AAP guidelines
(HealthDay)—Application of the new 2017 American Academy of Pediatrics guideline on classification of hypertension status results in a weighted net
Continue reading »Gammaherpesviruses linked to tumors in macaques with simian immunodeficiency virus
Viruses known as gammaherpesviruses may raise the risk of cancer in macaques infected with Simian Immunodeficiency Virus or Simian Human
Continue reading »Results of Phase III (PIX306) Trial Evaluating Progression-Free Survival of Pixuvri (pixantrone) Combined with Rituximab in Patients with Aggressive B-cell Non-Hodgkin Lymphoma
SEATTLE, July 9, 2018 /PRNewswire/ — CTI BioPharma Corp. (NASDAQ:CTIC) and Servier today announced that the pivotal Phase III trial
Continue reading »Celgene and Acceleron Announce Luspatercept Achieved Primary and All Key Secondary Endpoints in Phase III ‘BELIEVE’ Study in Adults with Transfusion-Dependent Beta-Thalassemia
SUMMIT, N.J. & CAMBRIDGE, Mass.–July 9, 2018 (BUSINESS WIRE)– Celgene Corporation (NASDAQ: CELG) and Acceleron Pharma Inc. (NASDAQ: XLRN) today
Continue reading »Promising clinical trial results of tucatinib with T-DM1 against HER2+ breast cancer
Phase 1b clinical trial results published in JAMA Oncology show promise for the combination of tucatinib (formerly ONT-380) with T-DM1
Continue reading »Insurance gaps linked to five-fold rise in hospital stays for adults with type 1 diabetes
For a million American adults, living with type 1 diabetes means a constant need for insulin medication, blood sugar testing
Continue reading »